Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

Health Care

Health Care

Group By Ticker
Sort By
Newest | Oldest
Read More
1 minute read
  • Biotech
  • General
  • Health Care

Gilead Shares Climb On Positive Interim Analysis From Late-Stage Breast Cancer Study

By Ragothaman Srinivasan
August 15, 10:17 AM
Gilead Sciences, Inc. (NASDAQ: GILD) announced positive results from the second interim analysis of the key secondary endpoint of overall survival (OS) in the Phase 3 TROPiCS-02 study evaluating Trodelvy (sacituzumab govitecan-hziy) in patients with HR+/HER2- metastatic breast cancer.

GILD

Read More
1 minute read
  • Biotech
  • FDA
  • General
  • Health Care
  • Movers
  • News
  • Penny Stocks
  • Trading Ideas

BrainStorm To File US Application For NurOwn In Amyotrophic Lateral Sclerosis

By Vandana Singh
August 15, 9:49 AM
BrainStorm Cell Therapeutics Inc (NASDAQ: BCLI) announced its decision to submit a marketing application to the FDA seeking approval for NurOwn for…

BCLI

Read More
1 minute read
  • Biotech
  • General
  • Health Care
  • Penny Stocks

Anixa Initiates Patient Dosing in Initial-Stage Ovarian Cancer Study

By Ragothaman Srinivasan
August 15, 9:47 AM
Anixa Biosciences (NASDAQ: ANIX) commenced treatment of the first patient in the clinical trial of its novel chimeric antigen receptor T-cell (CAR-T) therapy for ovarian cancer.

ANIX

Read More
1 minute read
  • Biotech
  • FDA
  • General
  • Health Care
  • Movers
  • News
  • Trading Ideas

Novavax Seeks FDA Emergency Use Nod For Its COVID-19 Vaccine Booster

By Vandana Singh
August 15, 9:28 AM
Novavax Inc (NASDAQ:NVAX) has submitted an application to the FDA for Emergency Use Authorization (EUA) for its protein-based COVID-19 vaccine as…

NVAX

Read More
1 minute read
  • Biotech
  • Earnings
  • General
  • Health Care
  • Movers
  • News
  • Penny Stocks
  • Trading Ideas

Clene Shares Fall Despite Multiple Sclerosis Candidate Showing Neurological Improvements

By Vandana Singh
August 15, 9:04 AM
Clene Inc (NASDAQ:CLNN) has announced topline results from the Phase 2 VISIONARY-MS trial of CNM-Au, an investigational gold nanocrystal suspension, in…

CLNN

Read More
1 minute read
  • Biotech
  • General
  • Health Care

Virios Therapeutics Commences Mid-Stage Long-COVID Study

By Ragothaman Srinivasan
August 15, 8:27 AM
Virios Therapeutics (Nasdaq: VIRI) has initiated patient dosing in its exploratory Long-COVID trial evaluating IMC-2 (valacyclovir + celecoxib).

VIRI

Read More
2 minute read
  • General
  • Health Care
  • News

Here’s The ‘Terrible Habit’ Elon Musk Wants To Cut From His Morning Routine

By Bibhu Pattnaik
August 14, 10:54 AM
The world’s wealthiest person and CEO of Tesla Inc (NASDAQ: TSLA), Elon Musk, is a busy person, and maintains regular habits to balance his personal and professional life. 

TSLA

Read More
1 minute read
  • General
  • Government
  • Health Care
  • News
  • Politics

Bill Gates Lauds This World Leader For His Role In Advancing Global Health

By Shanthi Rexaline
August 13, 5:23 PM
Former Japanese Prime Minister Shinzo Abe, who was assassinated in July, is one leader who understood that improving health makes the world safer and more prosperous, billionaire Bill Gates said in a blog post this week.

MSFT

Read More
1 minute read
  • Analyst Ratings
  • Biotech
  • Downgrades
  • General
  • Health Care
  • News
  • Penny Stocks

Raymond James Is Bearish On This Inflammatory Bowel Disease Player On Upcoming ‘Pipeline Reset’

By Vandana Singh
August 12, 6:37 PM
Raymond James downgraded Landos Biopharma Inc (NASDAQ:LABP) to Market Perform from Outperform following 2Q22 earnings and the first look at NX-13…

LABP

Read More
1 minute read
  • Analyst Color
  • Analyst Ratings
  • Earnings
  • General
  • Health Care
  • Large Cap
  • News

Competitor Recall Continues To Show Opportunities For ResMed

By Vandana Singh
August 12, 6:34 PM
ResMed Inc (NYSE:RMD) posted Q4 sales of $914.7 million, +4% Y/Y (+8% on a constant currency basis), beating the consensus…

PHG

Posts pagination

Previous 1 … 443 444 445 … 478 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service